Entity

Time filter

Source Type

San Francisco, CA, United States

Compounds are provided having a structure according to Formula (I): wherein A


Patent
Elan Pharmaceuticals Inc. | Date: 2014-03-12

The present invention provides compounds having a structure according to Formula I. The invention further provides pharmaceutical compositions including the compounds of the invention and methods of making and using the compounds and compositions of the invention, e.g., in the treatment and prevention of various disorders, such as Parkinsons disease.


Patent
Elan Pharmaceuticals Inc. | Date: 2013-04-17

The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, X, R


Patent
Elan Pharmaceuticals Inc. | Date: 2015-01-14

The present invention provides compounds having a structure according to Formula (I): or a salt or solvate thereof, wherein ring A, X, R


Patent
Elan Pharmaceuticals Inc. | Date: 2013-03-15

Disclosed are conjugates which bind VLA-4. Certain of these conjugates also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. Such conjugates are useful in the treatment of inflammatory diseases in a mammalian patient, e.g., human, such as asthma, Alzheimers disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumor metastasis and myocardial ischemia. The conjugates can also be administered for the treatment of inflammatory brain diseases such as multiple sclerosis.

Discover hidden collaborations